Santini, Stefano Angelo
 Distribuzione geografica
Continente #
EU - Europa 1.414
NA - Nord America 1.389
AS - Asia 621
SA - Sud America 69
AF - Africa 3
OC - Oceania 1
Totale 3.497
Nazione #
US - Stati Uniti d'America 1.375
DE - Germania 358
SE - Svezia 288
CN - Cina 261
SG - Singapore 203
IT - Italia 177
UA - Ucraina 163
FR - Francia 106
IE - Irlanda 80
GB - Regno Unito 77
BR - Brasile 63
RU - Federazione Russa 52
ID - Indonesia 49
FI - Finlandia 48
IN - India 44
NL - Olanda 17
TR - Turchia 16
HK - Hong Kong 13
BE - Belgio 12
CA - Canada 11
VN - Vietnam 8
AT - Austria 7
PL - Polonia 5
RO - Romania 5
DK - Danimarca 4
JP - Giappone 4
GR - Grecia 3
IL - Israele 3
IR - Iran 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
CL - Cile 2
KG - Kirghizistan 2
KR - Corea 2
MX - Messico 2
NO - Norvegia 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
ES - Italia 1
GE - Georgia 1
HU - Ungheria 1
IQ - Iraq 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
ML - Mali 1
NZ - Nuova Zelanda 1
PE - Perù 1
PT - Portogallo 1
PY - Paraguay 1
TH - Thailandia 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 3.497
Città #
Chandler 255
Ashburn 143
Singapore 117
Jacksonville 109
Dublin 79
San Mateo 78
Nanjing 67
Woodbridge 55
Jakarta 49
New York 49
Marseille 47
Ann Arbor 44
Dearborn 41
Wilmington 37
Lancaster 36
Moscow 32
Boston 28
Detroit 27
Milan 27
Princeton 26
Nanchang 25
Rome 23
Nürnberg 21
Redwood City 20
Cattolica 17
Helsinki 17
Los Angeles 17
Beijing 16
Houston 15
Kunming 15
Seattle 15
Bologna 14
Munich 14
Fairfield 13
Hebei 13
Izmir 13
Lawrence 13
Brussels 12
University Park 12
Hangzhou 11
Hong Kong 11
Norwalk 11
Shanghai 11
Bremen 10
Guangzhou 10
Nuremberg 10
Tianjin 10
Shenyang 9
Hounslow 8
Jiaxing 8
Leawood 8
Cambridge 7
London 7
Boardman 6
Changchun 6
Frankfurt am Main 6
Molfetta 6
Ypsilanti 6
Zhengzhou 6
Atlanta 5
Changsha 5
Hanoi 5
Manduria 5
Mountain View 5
São Paulo 5
Augusta 4
Capriolo 4
Caxias do Sul 4
Falkenstein 4
Falls Church 4
Florinas 4
Hyderabad 4
Lappeenranta 4
North Bergen 4
Ottawa 4
Paris 4
Warsaw 4
Athens 3
Berlin 3
Brasília 3
Busto Arsizio 3
Curitiba 3
Des Moines 3
Dong Ket 3
Esslingen am Neckar 3
Hefei 3
Lauterbourg 3
Manerbio 3
Parma 3
Rio de Janeiro 3
Sierra Vista 3
Tashkent 3
Toronto 3
Vienna 3
Afyonkarahisar 2
Ancona 2
Andover 2
Baku 2
Bari 2
Bishkek 2
Totale 1.959
Nome #
Increased levels of IGF-1 and beta2-microglobulin in epithelial lining fluid of preterm newborns developing chronic lung disease effects of rhG-CSF 156
NA+/K+ ATPase impairment and experimental glycation: the role of glucose autoxidation 117
Early prediction of postthyroidectomy hypocalcemia by one single iPTH measurement 115
Oxidative stress, nitric oxide and diabetes. 115
Chronic taaurine supplementation ameliorates oxidative stress and Na+ K+ ATPase impairment in the retina of diabetic rats 110
Evaluation of screening method for Bence Jones protein analysis 103
Role of cytochrome P4502D6 functional polymorphisms in the efficacy of donepezil in patients with Alzheimer's disease 101
Quantitative Determination of 18-β-Glycyrrhetinic Acid in HepG2 Cell Line by High Performance Liquid Chromatography Method. 100
Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM 98
Comparison between real-time quantitative PCR detection of HER2 mRNA copy number in peripheral blood and ELISA of serum HER2 protein for determining HER2 status in breast cancer patients 96
Metabolic implications of coenzyme Q10 in red blood cells and plasma lipoproteins 95
The interaction of short chain coenzyme Q analogs with different redox states of myoglobin 94
How future surgery will benefit from SARS-COV-2-related measures: a SPIGC survey conveying the perspective of Italian surgeons 93
Effectiveness of a High-Throughput Genetic Analysis in the Identification of Responders/Non-responders to CYP2D6-Metabolized Drugs 93
Comparison of nitrite/nitrate concentration in human plasma and serum samples measured by the enzymatic batch Griess assay, ion-pairing HPLC and ion-trap GC-MS: The importance of a correct removal of proteins in the Griess assay. 91
Paradoxical inhibition of cardiac lipid peroxidation in cancer patients treated with doxorubicin. Pharmacologic and molecular reappraisal of anthracycline cardiotoxicity 89
Oxidative stress in ischemia-reperfusion injury: assessment by three independent biochemical markers 88
Alkaline phosphatase inactivation by mixed function oxidation systems 82
A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders 81
Vitamin D and parameters of calcium homeostasis in inpatients with and without type 2 diabetes mellitus 80
Increased cardiovascular risk among type 2 diabetic patients with high-normal albuminuria and no evidence of kidney impairment 79
Antioxidant effect of coenzyme Q on hydrogen peroxide-activated myoglobin 78
NMR-Based Metabolomics for the Assessment of Inhaled Pharmacotherapy in Chronic Obstructive Pulmonary Disease Patients 77
Pharmacogenetics in older people: what we know and what we need to know 76
Novel human pathological mutations. Gene symbol: UROD. Disease: porphyria, cutanea tarda 76
Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients 76
TYPE 2 DEIODINASE POLYMORPHISM (THR92ALA) PREDICTS L-THYROXINE DOSE TO ACHIEVE TARGET TSH LEVELS IN THYROIDECTOMIZED PATIENTS 73
The ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) K121Q polymorphism modulates the beneficial effect of weight loss on fasting glucose in non-diabetic individuals 73
Plasmatic free light chains as inflammatory marker in insulin resistance: comparison of metabolic syndrome with adult growth hormone deficiency 66
The ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) K121Q polymorphism modulates the beneficial effect of weight loss on fasting glucose in non-diabetic individuals 65
Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia 64
IgG cryoglobulinemia 62
Comparison of Fully Automated and Semiautomated Systems for Protein Immunofixation Electrophoresis 62
Lack of association between Vitamin D status and free light chains profile with different chronic HCV-related liver and extrahepatic disorders 60
Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins 59
Free radical production by activated haem proteins: protective effect of coenzyme Q 58
Regulation of PTH secretion by 25-hydroxyvitamin D and ionized calcium depends on vitamin D status: a study in a large cohort of healthy subjects 55
Enzyme inactivation by metal-catalyzed oxidation of coenzyme Q1 54
SARS-CoV-2 was already circulating in Italy, in early December 2019 44
Role of CYP2D6 Polymorphisms in the Outcome of Postoperative Pain Treatment 43
Vitamin D status in primary hyperparathyroidism: effect of genetic background 42
Modifications in Nasal Function and Nitric Oxide Serum Level in Type 1 Diabetes 34
Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2 30
Opposite Effects of mRNA-Based and Adenovirus-Vectored SARS-CoV-2 Vaccines on Regulatory T Cells: A Pilot Study 29
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases 24
SARS-CoV-2 antibody responses before and after a third dose of the BNT162b2 vaccine in Italian healthcare workers aged ≤60 years: One year of surveillance 19
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity 18
COVID-19 vaccine immunogenicity in 16 patients with autoimmune systemic diseases. Lack of both humoral and cellular response to booster dose and ongoing disease modifying therapies 18
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups 15
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 13
Totale 3.539
Categoria #
all - tutte 17.608
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.608


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202083 0 0 0 0 0 0 0 0 0 0 51 32
2020/2021271 5 27 1 29 29 10 40 3 42 23 51 11
2021/2022360 28 36 4 33 25 10 7 65 16 11 55 70
2022/2023786 91 135 57 114 58 85 58 60 73 9 28 18
2023/2024513 26 108 3 51 24 116 27 30 19 15 44 50
2024/2025530 25 44 68 30 63 48 31 16 135 62 8 0
Totale 3.539